AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury

Raymond R. Russell, Ji Li, David L. Coven, Marc Pypaert, Christoph Zechner, Monica Palmeri, Frank J. Giordano, James Mu, Morris J. Birnbaum, Lawrence H. Young

Research output: Contribution to journalArticle

Abstract

AMP-activated protein kinase (AMPK) is an important regulator of diverse cellular pathways in the setting of energetic stress. Whether AMPK plays a critical role in the metabolic and functional responses to myocardial ischemia and reperfusion remains uncertain. We examined the cardiac consequences of long-term inhibition of AMPK activity in transgenic mice expressing a kinase dead (KD) form of the enzyme. The KD mice had normal fractional shortening and no heart failure, cardiac hypertrophy, or fibrosis, although the in vivo left ventricular (LV) dP/dt was lower than that in WT hearts. During low-flow ischemia and postischemic reperfusion in vitro, KD hearts failed to augment glucose uptake and glycolysis, although glucose transporter content and insulin-stimulated glucose uptake were normal. KD hearts also failed to increase fatty acid oxidation during reperfusion. Furthermore, KD hearts demonstrated significantly impaired recovery of LV contractile function during postischemic reperfusion that was associated with a lower ATP content and increased injury compared with WT hearts. Caspase-3 activity and TUNEL-staining were increased in KD hearts after ischemia and reperfusion. Thus, AMPK is responsible for activation of glucose uptake and glycolysis during low-flow ischemia and plays an important protective role in limiting damage and apoptotic activity associated with ischemia and reperfusion in the heart.

Original languageEnglish (US)
Pages (from-to)495-503
Number of pages9
JournalJournal of Clinical Investigation
Volume114
Issue number4
DOIs
StatePublished - Aug 1 2004

Fingerprint

AMP-Activated Protein Kinases
Apoptosis
Phosphotransferases
Glucose
Reperfusion
Wounds and Injuries
Ischemia
Glycolysis
Myocardial Reperfusion
Facilitative Glucose Transport Proteins
In Situ Nick-End Labeling
Cardiomegaly
Left Ventricular Function
Caspase 3
Transgenic Mice
Myocardial Ischemia
Fibrosis
Fatty Acids
Heart Failure
Adenosine Triphosphate

ASJC Scopus subject areas

  • Medicine(all)

Cite this

AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. / Russell, Raymond R.; Li, Ji; Coven, David L.; Pypaert, Marc; Zechner, Christoph; Palmeri, Monica; Giordano, Frank J.; Mu, James; Birnbaum, Morris J.; Young, Lawrence H.

In: Journal of Clinical Investigation, Vol. 114, No. 4, 01.08.2004, p. 495-503.

Research output: Contribution to journalArticle

Russell, RR, Li, J, Coven, DL, Pypaert, M, Zechner, C, Palmeri, M, Giordano, FJ, Mu, J, Birnbaum, MJ & Young, LH 2004, 'AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury', Journal of Clinical Investigation, vol. 114, no. 4, pp. 495-503. https://doi.org/10.1172/JCI200419297
Russell, Raymond R. ; Li, Ji ; Coven, David L. ; Pypaert, Marc ; Zechner, Christoph ; Palmeri, Monica ; Giordano, Frank J. ; Mu, James ; Birnbaum, Morris J. ; Young, Lawrence H. / AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. In: Journal of Clinical Investigation. 2004 ; Vol. 114, No. 4. pp. 495-503.
@article{c9f3fd37ca0a4c8d9341d21002ddf1d0,
title = "AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury",
abstract = "AMP-activated protein kinase (AMPK) is an important regulator of diverse cellular pathways in the setting of energetic stress. Whether AMPK plays a critical role in the metabolic and functional responses to myocardial ischemia and reperfusion remains uncertain. We examined the cardiac consequences of long-term inhibition of AMPK activity in transgenic mice expressing a kinase dead (KD) form of the enzyme. The KD mice had normal fractional shortening and no heart failure, cardiac hypertrophy, or fibrosis, although the in vivo left ventricular (LV) dP/dt was lower than that in WT hearts. During low-flow ischemia and postischemic reperfusion in vitro, KD hearts failed to augment glucose uptake and glycolysis, although glucose transporter content and insulin-stimulated glucose uptake were normal. KD hearts also failed to increase fatty acid oxidation during reperfusion. Furthermore, KD hearts demonstrated significantly impaired recovery of LV contractile function during postischemic reperfusion that was associated with a lower ATP content and increased injury compared with WT hearts. Caspase-3 activity and TUNEL-staining were increased in KD hearts after ischemia and reperfusion. Thus, AMPK is responsible for activation of glucose uptake and glycolysis during low-flow ischemia and plays an important protective role in limiting damage and apoptotic activity associated with ischemia and reperfusion in the heart.",
author = "Russell, {Raymond R.} and Ji Li and Coven, {David L.} and Marc Pypaert and Christoph Zechner and Monica Palmeri and Giordano, {Frank J.} and James Mu and Birnbaum, {Morris J.} and Young, {Lawrence H.}",
year = "2004",
month = "8",
day = "1",
doi = "10.1172/JCI200419297",
language = "English (US)",
volume = "114",
pages = "495--503",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury

AU - Russell, Raymond R.

AU - Li, Ji

AU - Coven, David L.

AU - Pypaert, Marc

AU - Zechner, Christoph

AU - Palmeri, Monica

AU - Giordano, Frank J.

AU - Mu, James

AU - Birnbaum, Morris J.

AU - Young, Lawrence H.

PY - 2004/8/1

Y1 - 2004/8/1

N2 - AMP-activated protein kinase (AMPK) is an important regulator of diverse cellular pathways in the setting of energetic stress. Whether AMPK plays a critical role in the metabolic and functional responses to myocardial ischemia and reperfusion remains uncertain. We examined the cardiac consequences of long-term inhibition of AMPK activity in transgenic mice expressing a kinase dead (KD) form of the enzyme. The KD mice had normal fractional shortening and no heart failure, cardiac hypertrophy, or fibrosis, although the in vivo left ventricular (LV) dP/dt was lower than that in WT hearts. During low-flow ischemia and postischemic reperfusion in vitro, KD hearts failed to augment glucose uptake and glycolysis, although glucose transporter content and insulin-stimulated glucose uptake were normal. KD hearts also failed to increase fatty acid oxidation during reperfusion. Furthermore, KD hearts demonstrated significantly impaired recovery of LV contractile function during postischemic reperfusion that was associated with a lower ATP content and increased injury compared with WT hearts. Caspase-3 activity and TUNEL-staining were increased in KD hearts after ischemia and reperfusion. Thus, AMPK is responsible for activation of glucose uptake and glycolysis during low-flow ischemia and plays an important protective role in limiting damage and apoptotic activity associated with ischemia and reperfusion in the heart.

AB - AMP-activated protein kinase (AMPK) is an important regulator of diverse cellular pathways in the setting of energetic stress. Whether AMPK plays a critical role in the metabolic and functional responses to myocardial ischemia and reperfusion remains uncertain. We examined the cardiac consequences of long-term inhibition of AMPK activity in transgenic mice expressing a kinase dead (KD) form of the enzyme. The KD mice had normal fractional shortening and no heart failure, cardiac hypertrophy, or fibrosis, although the in vivo left ventricular (LV) dP/dt was lower than that in WT hearts. During low-flow ischemia and postischemic reperfusion in vitro, KD hearts failed to augment glucose uptake and glycolysis, although glucose transporter content and insulin-stimulated glucose uptake were normal. KD hearts also failed to increase fatty acid oxidation during reperfusion. Furthermore, KD hearts demonstrated significantly impaired recovery of LV contractile function during postischemic reperfusion that was associated with a lower ATP content and increased injury compared with WT hearts. Caspase-3 activity and TUNEL-staining were increased in KD hearts after ischemia and reperfusion. Thus, AMPK is responsible for activation of glucose uptake and glycolysis during low-flow ischemia and plays an important protective role in limiting damage and apoptotic activity associated with ischemia and reperfusion in the heart.

UR - http://www.scopus.com/inward/record.url?scp=4344583554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344583554&partnerID=8YFLogxK

U2 - 10.1172/JCI200419297

DO - 10.1172/JCI200419297

M3 - Article

VL - 114

SP - 495

EP - 503

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -